Gentamicin
Active ingredient · 5 therapeutic classes
- Drug class
- Other Aminoglycosides
- Availability
- Prescription only
- Routes
- Intramuscular, Ophthalmic, Intravenous, Topical
- Markets covered
- 3
- Products on record
- 32
Overview
Gentamicin is an active pharmaceutical ingredient in the Other Aminoglycosides group (J01GB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 21 | April 10, 2026 |
| CA Canada | Health Canada | 7 | January 29, 2026 |
| US United States | FDA | 4 | February 3, 2025 |
GBUnited Kingdom· MHRA
21 products
Uses
Indications : gentamicin is indicated in bacteraemia, urinary tract infections, chest infections, severe neonatal infections and other serious systemic infections due to susceptible organisms, in adults and children including neonates.
1. Consideration should be given to official local guidance on the appropriate use of antibacterial agents.
How to take
CACanada· Health Canada
7 products
Uses
Gentamicin Injection USP (gentamicin sulfate) is clinically effective in serious infections caused by susceptible strains of the following bacteria: Pseudomonas aeruginosa, Proteus species (indole negative and indole positive), Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Serratia marcescens, and Staphylococcus species (methicillin-susceptible strains only).
Gentamicin Injection USP (gentamicin sulfate) may be considered for the treatment of Staphylococcus infections when other less potentially toxic drugs are contraindicated and bacterial susceptibility tests and clinical judgment indicate its use.
The use of gentamicin is indicated in the treatment of serious infections caused by laboratory determined susceptible bacteria, with due regard for relative antibiotic toxicity. Therefore, the drug should be considered for treatment of: Bacteremia Respiratory tract infections Urinary tract infections Infected wounds: surgical and traumatic Bone and soft tissue infections, including peritonitis and burns complicated by sepsis In the majority of cases bacteriologic cultures should be obtained initially to identify the causative organism(s) and to determine susceptibility to gentamicin.
USUnited States· FDA
4 products
Uses
INDICATIONS AND USAGE:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Injection, USP and other antibacterial drugs, Gentamicin Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Gentamicin Injection, USP is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: Pseudomonas aeruginosa, Proteus species (indole-positive and indole-negative), Escherichia coli, Klebsiella-Enterobacter-Serratia species, Citrobacter species and Staphylococcus species (coagulase-positive and coagulase-negative).
Drug interactions
Known interactions involving Gentamicin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 264. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL298310660 · revised November 15, 2024
- [2]Health Canada (DPD) · 02457008 · revised March 22, 2025
- [3]FDA DailyMed · 09cf88af-59da-f1… · revised November 10, 2023 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.